Green light for cancer treatment for BRCA mutations

Approved for platinum-sensitive ovarian cancer Related items fromOnMedica Experts disappointed at NICE decision on ovarian cancer drug Put case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company Debate goes on over valproate in pregnancy HPV programme linked to dramatic fall in cervical disease Quarter million people taking benzodiazepines for more than a year
Source: OnMedica Latest News - Category: UK Health Source Type: news